Escolar Documentos
Profissional Documentos
Cultura Documentos
August
2016
Endothelin Receptor
Antagonists
Prostacyclin &
Prostacyclin Analogs
Phosphodiesterase V
Inhibitors
By Drug Class
USA
Canada
Coverage By Region
Europe
APAC
Latin America
MEA
North America
UK
COVERAGE BY COUNTRY
Germany
Japan
Brazil
South Africa
Research Methodology
Research Definition
The Global Pulmonary Arterial Hypertension Market Report comprises of the study of various aspects of pulmonary
arterial hypertension therapeutics market and forecast until 2021. Global Pulmonary Arterial Hypertension Market
has been segmented on type of drug class Endothelin receptor antagonists, Prostacyclin and Prostacyclin
Analogs,,Phosphodiesterase V Inhibitors and others; on region basis North America, Latin America, Europe, Asia
Pacific, Middle East and Africa.
Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market
segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by
reaching out industry experts across the value chain of the Global pulmonary arterial hypertension market.
For Forecasting purpose we have accessed some of the paid databases such as Bloomberg, Reuters, Factiva, Hoovers etc.
Companies Contacted
Actelion Pharmacuticals, Gilead Sciences, Pfizer, Glaxo Smithkline, United Therapeutics,
Figure
4:
Global
PAH
Market,
2016E-2021F
Billion)
(USD
xx
xx
xx
xx
xx
xx
xx
xx
xx
xx
xx
2011
2012
2013
2014
2016E
2015
2017F
2018F
2019F
2020F
2021F
Endothelin
receptor
antagonists
xx
xx
xx
Prostacylin and
Prostacyclin
Analogs
xx
Phosphodiestera
se V Inhibitors
Phosphodiestera
se V Inhibitors
xx
xx
Prostacylin and
Prostacyclin
Analogs
xx
others
xx
others
xx
2011
xx
2012
xx
xx
xx
xx
2013
2014
2015
2016E
xx
2017F
xx
2018F
xx
2019F
xx
2020F
xx
2021F
xx
2011
xx
2012
xx
xx
xx
xx
2013
2014
2015
2016E
xx
2017F
xx
2018F
xx
2019F
xx
2020F
xx
2021F
xx
2011
xx
2012
xx
xx
xx
xx
2013
2014
2015
2016E
xx
2017F
xx
2018F
xx
2019F
xx
2020F
xx
2021F
Billion)
xx
2011
xx
2012
xx
xx
xx
xx
2013
2014
2015
2016E
xx
2017F
xx
2018F
xx
2019F
xx
2020F
xx
2021F
Billion)
xx
2011
xx
2012
xx
xx
xx
xx
2013
2014
2015
2016E
xx
2017F
xx
2018F
xx
2019F
xx
2020F
xx
2021F
Figure 22: APAC PAH Market , 2011-2015 (USD Million) Figure 23: APAC PAH Market , 2016E - 2021F (USD
Million)
xx
2011
xx
2012
xx
xx
xx
xx
2013
2014
2015
2016E
xx
2017F
xx
2018F
xx
2019F
xx
2020F
xx
2021F
Million)
(USD Million)
xx
2011
xx
2012
xx
xx
xx
xx
2013
2014
2015
2016E
xx
2017F
xx
2018F
xx
2019F
xx
2020F
xx
2021F
xx
2011
xx
2012
xx
xx
xx
xx
2013
2014
2015
2016E
xx
2017F
xx
2018F
xx
2019F
xx
2020F
xx
2021F
Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country):
Opportunities and Forecasts (2016-2021)
For Details, Please Follow the Link Below:
http://www.azothanalytics.com/report/healthcare-pharma/global-pulmonary-arterialhypertension-pah-market-by-drug-class-by-region-by-country-opportunities-andforecasts-2016-2021-r58
Contact Us:
binny@azothanalytics.om
+91 9873-4262-88
About Azoth Analytics Pvt Ltd.
Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary
research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and
industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and
local clients. We provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and
gas, retail, automotive, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors .
10